Approval · Notice of Compliance 30145 · 2023
METVIX: Notice of Compliance 30145
Issued February 17, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30145
- Date
- February 17, 2023
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the indications, warnings and precautions & dosage and administration sections of the Product Monograph. Product Monograph reformatted to the master template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METVIX | Not yet assigned | — |
Medicinal ingredients
- METHYL AMINOLEVULINATE HYDROCHLORIDE 168 MG per G